B41.9
Paracoccidioidomycosis, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Paracoccidioidomycosis is a fungal infection caused by the Paracoccidioides species. It predominantly affects individuals in certain regions of Central and South America. The disease often begins in the lungs after inhalation of fungal spores and can spread to other parts of the body if not diagnosed and treated early. The term 'unspecified' in its ICD-10 code indicates that specific details about the manifestation or location of the infection might not be provided or documented.
Causes & Symptoms
Clinical Causes: Inhalation of spores from Paracoccidioides fungi present in soil, especially in rural or agricultural environments Occupational exposure, such as farming or working in areas with contaminated soil Potential environmental factors that favor fungal growth, like humid and warm climates
Key Symptoms: Chronic cough or chest discomfort Lesions or ulcers in the mouth and gums Persistent fever and fatigue Swollen lymph nodes Weight loss and night sweats In some cases, skin lesions or nodules Respiratory difficulties, especially as the infection advances
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical examination, medical history assessment, and laboratory tests. These tests may include:
Treatment Protocols: Treatment strategies involve antifungal medications prescribed for an extended period, often several months. Common treatments include:
Clinical Advice & FAQs
Billing Guidance
Is B41.9 a billable ICD-10 code?
Yes, B41.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B41.9?
Clinical documentation must specify the nature of Paracoccidioidomycosis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference